J. E. Davis

CEO and President

J. E. Davis (CEO and President) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $10.6M of DGX (55,093 sh across 3 lots, as filed), executed Nov 25 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$17.1M

shares × price, as filed

Last traded

Sep 1

Filed Sep 3

Median ADV $221.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $23.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

DGX

Quest Diagnostics Incorporated DGX · 0 buys · 5 sells 5 filings

Recent filings

DGXSALE Quest Diagnostics Incorporated View filing → $2.4M
10,000 sh × $242.72
Exec Sep 1
Filed Sep 3 · 5:05 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $1.9M
10,000 sh × $194.14
Exec Jun 1
Filed Jun 2 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $2.1M
10,000 sh × $212.52
Exec Mar 2
Filed Mar 4 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $10.6M
55,093 sh across 3 lots
Exec Nov 25 2025
Filed Nov 28 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated View filing → $6.4M
37,887 sh across 12 lots
Exec Apr 2 2025
Filed Apr 4 2025 · 5:30 PM ET